title: Patients with normocalcemic primary hyperparathyroidism may have similar metabolic profile as hypercalcemic patients.
abstract: Primary hyperparathyroidism is well known to be associated with cardiovascular morbidity and mortality. However, it is unclear whether normocalcemic primary hyperparathyroidism (NC-PHPT) and hypercalcemic primary hyperparathyroidism (HC-PHPT) share the same risk factors. We aimed to determine prevalence of metabolic syndrome in NC-PHPT and compare metabolic syndrome parameters and insulin resistance in NC-PHPT subjects with those in HC-PHPT and control subjects. After excluding patients with secondary hyperparathyroidism, the study enrolled 25 patients with NC-PHPT, 24 patients with HC-PHPT and 30 age-gender matched controls. All participants were evaluated using the International Diabetes Federation (IDF)-2006 metabolic syndrome criteria. Compared with HC-PHPT patients, NC-PHPT patients had similar prevalence of metabolic syndrome, glucose intolerance, and previous history of hypertension/anti-hypertensive medications, but compared with controls, NC-PHPT patients had significantly higher prevalence of glucose intolerance and previous history of hypertension/anti-hypertensive medications. Not serum calcium but PTH concentration was found to be significantly higher in those with glucose intolerance. Serum fasting triglyceride concentration and waist circumference were found to be positively correlated only with serum PTH concentration. In conclusion, patients with NC-PHPT may be prone to similar metabolic disturbances linked to higher cardiovascular risk like patients with HC-PHPT. Although NC-PHPT is thought to occur early in the development of the classical disease, it should be monitored regularly because of its metabolic consequences.
authors.affiliation: Department of Endocrinology and Metabolism, Sisli Hamidiye Etfal Training and Research Hospital, Istanbul, Turkey.
authors.forename: Feyza
authors.initials: F
authors.lastname: Yener Ozturk
authors.forename: Selvinaz
authors.initials: S
authors.lastname: Erol
authors.forename: Muhammed Masum
authors.initials: MM
authors.lastname: Canat
authors.forename: Savas
authors.initials: S
authors.lastname: Karatas
authors.forename: Idris
authors.initials: I
authors.lastname: Kuzu
authors.forename: Sezin
authors.initials: S
authors.lastname: Dogan Cakir
authors.forename: Yuksel
authors.initials: Y
authors.lastname: Altuntas
mesh_terms: D000328:Adult; D002118:Calcium / Q000097:blood*; D016022:Case-Control Studies; D005260:Female; D018149:Glucose Intolerance / Q000150:complications / Q000378:metabolism; D006801:Humans; D006934:Hypercalcemia / Q000097:blood / Q000378:metabolism*; D049950:Hyperparathyroidism, Primary / Q000097:blood / Q000378:metabolism*; D007333:Insulin Resistance; D008297:Male; D024821:Metabolic Syndrome / Q000150:complications / Q000378:metabolism; D055442:Metabolome / Q000502:physiology*; D008875:Middle Aged
chemical_list: D002118:Calcium